Penserra Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-720	Closed	-$72K	–	1604
2021 Q3	$72K	Buy	720 +5	+0.7%	+$500	﹤0.01%	938
2021 Q2	$101K	Buy	715 +15	+2%	+$2.12K	﹤0.01%	787
2021 Q1	$69K	Buy	700 +35	+5%	+$3.45K	﹤0.01%	764
2020 Q4	$82K	Buy	+665	New	+$82K	﹤0.01%	616